Terns Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Terns Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $704k | 109k | 6.49 |
2023-09-30 | $108k | 22k | 5.03 |
2023-06-30 | $464k | 53k | 8.75 |
2023-03-31 | $67k | 5.7k | 11.84 |
2022-09-30 | $22k | 3.7k | 6.00 |
2021-12-31 | $27k | 3.8k | 7.15 |
2021-03-31 | $56k | 2.5k | 22.00 |